Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
spiriTED: TOUR006 in Thyroid Eye Disease
NCT06088979Phase 2Active, not recruiting
- Sponsor
- Tourmaline Bio, Inc.
- Start
- Feb 2024
- Primary completion
- Sep 2026
- Modality
- Monoclonal Antibodies
- Countries
- 11
01
Overview
A Phase 2 trial of pacibekitug in thyroid eye disease (TED), sponsored by Tourmaline Bio, Inc.. Started Feb 2024; status: active, not recruiting.
02
Drugs
pacibekitug
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT06088979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06088979.